Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with ...

COURT: D.N.J. TRACK DOCKET: No. 2:25-cv-00713 (Bloomberg Law subscription) A Novo Nordisk A/S investor says the pharmaceutical company’s failure to disclose how it tested experimental obesity shot ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

WICHITA, Kan. (KWCH) - Scattered rain showers should continue to move through Kansas into the night and early morning hours of Thursday. While some thunder remains possible in spots, rainfall in m ...

You want boring magic? You have it here. Not that the GT3 is in any way boring, but to get a 500bhp naturally aspirated petrol engine through the new emissions regs is nothing short of Gandalf ...

The Scan Engine and EtherCAT Custom Device allows users to integrate I/O from several hardware platforms that are not natively supported by VeriStand: ...